industry pr

Press release news from the public relations clients of Tiziani Whitmyre, Inc.

Posts Tagged ‘cell culture’


Wednesday, December 1st, 2010

InQ Biosciences to Introduce First Integrated Cell Research System at ASCB Annual Meeting

Huntsville, Ala. – December 1, 2010– InQ Biosciences, a provider of innovative technologies for cell growth and research, will introduce its InQ™ Cell Research System – the first fully integrated cell growth and cell analysis system that combines a dynamically controlled sample environment with powerful imaging and real-time data collection – at the American Society for Cell Biology’s (ASCB) 2010 Annual Meeting in Philadelphia.

In addition, Candace L. Floyd, Ph.D., assistant professor in the Department of Physical Medicine and Rehabilitation at the University of Alabama at Birmingham and its Center for Glial Biology in Medicine, will discuss her experience testing the efficacy of the InQ system and its ability to grow various types of brain cells of equal or better quality than those grown in a Petri dish.

Dr. Floyd has already confirmed the growth of “exceptionally well formed” astrocytes and neurons as well as cardiac myocytes using the InQ system and is continuing to test the development of other cell types used in medical research. She is a member of the InQ Biosciences Scientific Advisory Board.

“The InQ system accurately models the conditions found in the human body that are essential for healthy cell growth and analysis. It is an essential tool for researchers studying the effects of disease and environment on human and animal cells,” said Aaron Hammons, InQ Biosciences president and chief technology officer.

“The InQ system’s exclusive ability to control environmental parameters with correlated real-time sample feedback empowers researchers with novel and efficient approaches to discovery,” he said.

InQ technology is the first to offer:

  • The ability to create a high-fidelity simulation of the human body environment
  • Precise management of temperature, gas levels, media perfusion, and pressure for extended cell growth
  • Advanced automated onboard microscopy with remote monitoring for superior cell analysis
  • Unprecedented reproducibility and standardization
  • Greater visualization and exceptional data quality

For more information, visit InQ Biosciences in booth #849 at the ASCB 2010 Annual Meeting, Dec. 11-15 in Philadelphia, or visit the company’s website at http://www.inqbio.com. Follow InQ bio on Twitter at @InQBio or http://twitter.com/inqbio.

About InQ Biosciences

InQ Biosciences is a provider of innovative technologies for cell growth and research. The company’s InQ Cell Research System will empower scientists to unlock novel and more powerful approaches to cell-based discovery. The firm was founded in 2007 with technology originating from the University of Alabama in Huntsville. Series B financing was completed in May 2010 and commercial launch of its InQ system is scheduled for the first quarter of 2011. For more information, visit www.inqbio.com. Follow InQ Biosciences on Twitter at @InQbio (http://twitter.com/InQbio).

# # #

Public Relations contact, Boston:  Don Goncalves, dgoncalves@tizinc.com, 781-793-9380, for Tiziani Whitmyre Inc., http://www.tizinc.com/public-relations


Monday, November 22nd, 2010

InQ Biosciences Announces New Board Members

Huntsville, Ala. – InQ Biosciences Corporation, a provider of innovative technologies for cell growth and research, announced that Michael Chambers and John R. Cooper have been appointed to the board of directors.

“Michael and John bring successful leadership and deep experience in life science and technology to the Board. We look forward to applying their spirit of innovation and success to the growth of InQ Biosciences,” said Dick Reeves, chairman and chief executive officer, InQ Biosciences.

Michael Chambers, Ph.D. is President and CEO of Swift Biotechnology, an emerging company targeting development of cancer diagnostics. He actively invests in early-stage high-growth companies and serves on the board of ProUroCare, a publicly traded company. Previously, Chambers helped establish InnoRx Pharmaceuticals in 1999, a company specializing in development of drugs and drug delivery systems for ocular disease. He served as president and CEO of InnoRx until negotiating its sale and merger into SurModics.

John Cooper is the retired chairman and CEO of publicly traded Avocent Corporation. From 2002 until 2008, he led Avocent through a period of rapid growth to become one of the largest companies in local and remote IT infrastructure management. From 1996 to 2001, Mr. Cooper was chief financial officer and senior vice president for finance and administration, of publicly traded ADTRAN, Inc., a leading global provider of networking and telecommunications solutions with revenues of $300 million.

InQ Biosciences provides the InQTM Cell Research System, the first fully integrated system that creates an in vivo-like environment for studying sensitive nerve, brain, and other human cells for disease research. It is the only cell research instrument that combines a dynamic software-controlled sample environment with powerful imaging and real-time data collection. These unique capabilities enable researchers to achieve unprecedented cell culture control, viability, and visibility that was previously unattainable.

About InQ Biosciences

InQ Biosciences is a provider of innovative technologies for cell growth and research. The company’s InQ Cell Research System will empower scientists to unlock novel and more powerful approaches to cell-based discovery. The firm was founded in 2007 with technology originating from the University of Alabama in Huntsville. Series B financing was completed in May 2010 and commercial launch of its InQ system is scheduled for the fourth quarter of 2010. For more information, visit http://www.inqbio.com. Follow InQ Biosciences on Twitter at @InQbio (http://twitter.com/InQbio).

# # #

Public Relations contact, Boston:  Don Goncalves, dgoncalves@tizinc.com, 781-793-9380, for Tiziani Whitmyre Inc., http://www.tizinc.com/public-relations


Tuesday, August 3rd, 2010

InQ Biosciences Appoints John Ryder as Senior Vice President, Sales & Marketing

Huntsville, Ala. and Marlborough, Mass., August 3, 2010InQ Biosciences Corporation, a provider of innovative technologies for cell growth and research, announced the appointment of John Ryder as Senior Vice President, Sales and Marketing. Ryder will be based in InQ’s sales office in Marlborough, Massachusetts.john-ryder-inqbiosciences

“Mr. Ryder’s responsibilities will include developing our sales channels, creating a strategic marketing plan, and building the InQ brand around the world,” said Dick Reeves, Chairman and Chief Executive Officer, InQ Biosciences.

“With his deep life sciences experience, he is the ideal executive to help us commercialize and launch the InQ Cell Research System. We are locating Mr. Ryder in the Boston area — the center of the stem cell and neuroscience research markets that will so greatly benefit from our exciting new technology,” Reeves said.

InQ is the first fully integrated system that creates a true in vivo environment for studying sensitive nerve, brain, and other human cells for disease research. It is the only cell research instrument that combines a dynamic software-controlled sample environment with powerful imaging and real-time data collection. These unique capabilities enable researchers to achieve unprecedented cell culture control, viability, and visibility that was previously unattainable.

Ryder brings over 20 years of life science sales, marketing, and business development leadership to InQ Biosciences. He joined the company from Skyscape, Marlborough, Massachusetts, a provider of trusted medical information for hand-held and mobile devices, where he was Senior Vice President of Sales. In that role, Ryder was instrumental in facilitating the acquisition of Skyscape in July 2009 by Physicians Interactive and Perseus, a $2 billion private equity firm. He also led sales and marketing for Advanced Instruments, Norwood, Massachusetts, a leading provider of microbiology research instrumentation to the pharmaceutical, industrial, and research markets. In addition, Ryder held sales management positions with Baxter Healthcare, Becton Dickinson Corporation, and Fisher Scientific. He holds a BS degree in Health Science Education from Springfield College in Massachusetts.

About InQ Biosciences
InQ Biosciences is a provider of innovative technologies for cell growth and research. The company’s InQ Cell Research System will empower scientists to unlock novel and more powerful approaches to cell-based discovery. The firm was founded in 2007 with technology originating from the University of Alabama in Huntsville. Series B financing was completed in May 2010 and commercial launch of its InQ system is scheduled for the fourth quarter of 2010. For more information, visit www.inqbio.com. Follow InQ Biosciences on Twitter at @InQbio (http://twitter.com/InQbio).

# # #

Public Relations contact, Boston:  Don Goncalves, dgoncalves@tizinc.com, 781-793-9380, for Tiziani Whitmyre Inc., http://www.tizinc.com/public-relations


Tuesday, July 13th, 2010

InQ Biosciences Introduces First Fully Integrated Cell Research System

HUNTSVILLE, ALABAMA, U.S.A., July 13, 2010 — InQ Biosciences, a provider of innovative technologies for cell growth and research, announced its plans to launch the InQTM Cell Research System during the fourth quarter of 2010. InQ is the first fully integrated system that creates a high fidelity in vivo environment for studying stem cells, plus nerve, brain, and other mammalian cells for disease research.

“The InQ system is the only cell research instrument that combines a dynamic software-controlled sample environment with powerful imaging and real-time data collection,” said Aaron Hammons, President and Chief Technology Officer, InQ Biosciences. “Our system’s exclusive capability to tightly control environmental parameters with correlated sample feedback will create a new paradigm in cell biology research. Scientists will be empowered with novel and more relevant approaches to discovery as they pursue the causes of cancer and neurodegenerative and cardiovascular diseases,” Hammons said.

The benchtop system automates the cell culture process by enclosing the cells in a sealed, sterile removable cartridge that slides into the instrument. An onboard computer precisely controls the mix and flow of nutritive media and gasses and regulates the temperature. “Users will reap the benefits of extended cell growth and unprecedented experiment reproducibility and standardization. Now researchers can easily simulate hundreds of disease states, including stroke, heart attack, Alzheimer’s, and ALS,” said Hammons.

A built-in high-resolution microscope and camera record the assay at scheduled intervals, and can send the images to the researcher anywhere in the world via the Internet and smart phone. Adjustments to the experiment can be made remotely, as well.

The InQ System fits easily into research workflows and integrates with most laboratory information management systems. It requires fewer samples to attain study goals, generates more data points for greater accuracy of results, and dramatically reduces the number of failed experiments,” Hammons said.

Units will be shipped to early access partners beginning in September, with commercial launch scheduled in the fourth quarter. For more information on the InQ System, contact info@inqbio.com or 866-735-9684, or visit http://www.inqbio.com. Follow InQ Biosciences on Twitter at http://twitter.com/InQbio.

About InQ Biosciences

InQ Biosciences is a provider of innovative technologies for cell growth and research. The company’s InQ Cell Research System will empower scientists to unlock novel and more powerful approaches to cell-based discovery. The firm was founded in 2007 with technology originating from the University of Alabama in Huntsville. Series B financing was completed in May 2010 and commercial launch of its InQ system is scheduled for the fourth quarter of 2010. For more information, visit http://www.inqbio.com. Follow InQ Biosciences on Twitter at http://twitter.com/InQbio.

# # #

Public Relations contact, Boston:  Don Goncalves, dgoncalves@tizinc.com, 781-793-9380, for Tiziani Whitmyre Inc., http://www.tizinc.com/public-relations


B2B News is proudly powered by WordPress.
WordPress